<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Gastroesophageal reflux and asthma</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Gastroesophageal reflux and asthma</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Gastroesophageal reflux and asthma</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan M Harding, MD, FCCP, AGAF</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter J Barnes, DM, DSc, FRCP, FRS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Dieffenbach, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 12, 2021.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Gastroesophageal (GE) reflux is common in patients with asthma and has been identified as a potential trigger for asthma [<a href="#rid1">1-4</a>]. GE reflux is a comorbidity associated with severe or difficult-to-treat asthma. An evidence-based guide for the diagnosis, evaluation, and treatment of asthma advises that GE reflux be evaluated and treated, especially in poorly controlled or severe asthma [<a href="#rid5">5</a>]. GE reflux is thought to affect asthma through the activation of vagal reflexes and/or microaspiration.</p><p>The term gastroesophageal reflux disease (GERD) refers to symptoms or signs suggestive of reflux [<a href="#rid6">6</a>]. The typical symptoms of GERD are heartburn and regurgitation. Other symptoms suggestive of GERD include dysphagia, chest pain, hypersalivation, globus sensation, odynophagia, and nausea. Esophageal inflammation is not necessarily present.</p><p>The relationship between GE reflux and asthma will be reviewed here. Other issues related to GERD are discussed separately. (See  <a class="medical medical_review" href="/d/html/2265.html" rel="external">"Clinical manifestations and diagnosis of gastroesophageal reflux in adults"</a> and  <a class="medical medical_review" href="/d/html/2258.html" rel="external">"Medical management of gastroesophageal reflux disease in adults"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">PREVALENCE</span><span class="headingEndMark"> — </span>Respiratory symptoms, including those associated with asthma (eg, cough, dyspnea, wheeze, and chest tightness), are increased among patients with gastroesophageal (GE) reflux [<a href="#rid7">7</a>]. Reciprocally, GE reflux is common among patients with asthma. However, GE reflux is most likely <strong>not</strong> a contributor to asthma in patients <strong>without</strong> esophageal reflux symptoms, based on the results of randomized trials of acid suppression therapy [<a href="#rid8">8,9</a>]. (See <a class="local">'Management of patients without symptoms of GERD'</a> below.)</p><p>Estimates of the prevalence of GE reflux among patients with asthma have varied from 30 to 90 percent [<a href="#rid3">3,10-23</a>]. Part of the variability may be due to differences in the definition of GE reflux, and the extent to which objective measures of reflux were used.</p><p>The following examples illustrate the range of findings:</p><p class="bulletIndent1"><span class="glyph">●</span>Among 341 patients with severe asthma enrolled in The <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww-sciencedirect-com.ezproxy.bu.edu%2Ftopics%2Fmedicine-and-dentistry%2Fcohort-effect&amp;token=Zu3k2C9vYl2j%2BZ%2BHgRjaLJoonmg4a2euae0EAHQNRBuYWv%2Bu%2BESHEUzGu9CE6f5O1FoXA3P6cu8T5yhhUokKvcEde6LsAQ%2F%2F%2FSczkRUG8FavALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=571" target="_blank">Epidemiology</a> and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR II) study, 46 percent had GE reflux disease [<a href="#rid2">2</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A systematic review of 28 studies of patients with asthma found GE reflux symptoms in 59 percent, abnormal 24-hour esophageal pH tests in 51 percent, hiatal hernia in 51 percent, and esophagitis in 37 percent [<a href="#rid21">21</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>One series included 199 patients with asthma who were referred for 24-hour esophageal pH testing [<a href="#rid17">17</a>]. Reflux symptoms were present in 164 patients (82 percent), of whom 118 (72 percent) had increased esophageal acid contact times. Among the patients with asthma and GE reflux, 80 percent reported respiratory symptoms that were associated with esophageal acid events. Of the 35 patients with asthma who did not have reflux symptoms, 10 (29 percent) had increased esophageal acid contact times consistent with the diagnosis of GE reflux.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another study, 104 consecutive patients with asthma and 44 control patients underwent esophageal manometry and 24-hour esophageal pH tests [<a href="#rid13">13</a>]. When compared with controls, the patients with asthma had decreased lower esophageal sphincter (LES) pressures, more frequent reflux episodes, and higher esophageal acid contact times (<a class="graphic graphic_figure graphicRef68486" href="/d/graphic/68486.html" rel="external">figure 1</a>). Acid reflux, as assessed by acid contact time, was noted in 82 percent of the asthma patients.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a population based survey in the United States not limited to individuals with asthma, 6 percent of respondents reported that they had significant (ie, occurring at least twice weekly) heartburn or regurgitation within the last month while 3 percent reported regurgitation. (See  <a class="medical medical_review" href="/d/html/2265.html" rel="external">"Clinical manifestations and diagnosis of gastroesophageal reflux in adults", section on 'Epidemiology'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An asthma phenotype evaluation in 1400 Turkish adult asthmatics noted that GE reflux was more frequent in non-allergic and uncontrolled asthma, than among those with allergic asthma [<a href="#rid24">24</a>]. However, GE reflux was not defined carefully in this cohort study.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>GE reflux (physician diagnosed) predicted poor quality of life (Mini-Asthma Quality of Life Questionnaire) in 165 older asthmatics (&gt;65 years old) [<a href="#rid25">25</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>GE reflux was an independent predictor associated with a risk of future asthma attacks in a longitudinal (&gt;3 years) medical record review of 118,981 patients with actively treated asthma from a United Kingdom electronic medical record database [<a href="#rid26">26</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>GE reflux was a frequent comorbidity (46 percent) in patients with severe or difficult-to-treat asthma in 341 patients enrolled in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II study [<a href="#rid2">2</a>].</p><p></p><p class="headingAnchor" id="H3"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>There are three postulated mechanisms whereby esophageal acid may produce bronchoconstriction and therefore exacerbate airflow obstruction in asthmatics: increased vagal tone, heightened bronchial reactivity, and microaspiration of gastric contents into the upper airway (<a class="graphic graphic_figure graphicRef80770" href="/d/graphic/80770.html" rel="external">figure 2</a>). Furthermore, gastroesophageal (GE) reflux can illicit neuroinflammation and increase exhaled oxidative stress biomarkers (8-isoprostane) [<a href="#rid27">27</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Increased vagal tone</span><span class="headingEndMark"> — </span>A number of observations suggest that exposure of the esophagus to acid can cause bronchoconstriction via a vagal mechanism [<a href="#rid28">28-32</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A Bernstein test, which is rarely obtained in clinical practice, is performed by alternately infusing <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> or acid into the mid-esophagus via a nasogastric tube or manometric assembly. A positive test is defined as reproduction of the patient's symptoms with acid perfusion but not with saline. Among patients with asthma who have a positive Bernstein test, a 10 percent increase in total respiratory resistance is observed [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/d/html/2265.html" rel="external">"Clinical manifestations and diagnosis of gastroesophageal reflux in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A reduction in peak expiratory flow rate (PEF) was detected during acid infusion into the esophagus in normal controls, patients with asthma plus GE reflux, patients with asthma without GE reflux, and patients with GE reflux alone [<a href="#rid29">29</a>]. Measures taken to improve esophageal acid clearance resulted in improved PEF in all groups except for the patients with asthma and GE reflux. These effects occurred with acid infusion into the mid-esophagus and were independent of proximal esophageal acid exposure (which is a prerequisite for microaspiration) (<a class="graphic graphic_figure graphicRef78222" href="/d/graphic/78222.html" rel="external">figure 3</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with asthma who received an infusion of acid into the esophagus had a reduction in the <a class="drug drug_general" data-topicid="9622" href="/d/drug information/9622.html" rel="external">methacholine</a> dose required to decrease the forced expiratory volume at one second (FEV<sub>1</sub>) by 20 percent (PD20), compared with patients with asthma who received an infusion of <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> (<a class="graphic graphic_figure graphicRef59750" href="/d/graphic/59750.html" rel="external">figure 4</a>) [<a href="#rid31">31</a>]. The effect was abolished with <a class="drug drug_general" data-topicid="8983" href="/d/drug information/8983.html" rel="external">atropine</a>. Thus, heightened bronchial reactivity may result from reflux, presumably mediated by vagal mechanisms [<a href="#rid20">20</a>].</p><p></p><p>A systematic review summarized the findings of 18 studies that evaluated pulmonary function during esophageal acid perfusion in adults with asthma [<a href="#rid33">33</a>]. FEV<sub>1</sub>, mid-expiratory flow rate, and peak expiratory flow rate did not change significantly in 97, 94, and 65 percent of patients, respectively. Changes in airway resistance were noted in 42 percent of patients. It is difficult to reach definitive conclusions based on this review because the studies included different subsets of patients, used different techniques in acid-perfusion, and monitored different airway responses.</p><p>The occurrence of respiratory symptoms following esophageal acid exposure may be due to factors other than bronchoconstriction. As an example, esophageal acid perfusion is associated with increases in respiratory rate and minute ventilation, particularly in patients with a positive Bernstein test [<a href="#rid34">34</a>]. This suggests that an increased minute ventilation may be responsible for worsening respiratory symptoms without a decrease in pulmonary function. However, the study was performed in subjects without asthma; whether these data can be applied to patients with asthma remains to be determined.</p><p class="headingAnchor" id="H5"><span class="h2">Heightened bronchial reactivity</span><span class="headingEndMark"> — </span>Esophageal reflux may also cause neural enhancement of bronchial reactivity, as suggested by the following studies. </p><p class="bulletIndent1"><span class="glyph">●</span>In a study of 105 consecutive patients with asthma, the degree of <a class="drug drug_general" data-topicid="9622" href="/d/drug information/9622.html" rel="external">methacholine</a> reactivity correlated with the number of episodes of reflux during 24-hour esophageal pH monitoring [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In non-asthmatic patients with GE reflux symptoms, 40 percent of patients with esophagitis had positive <a class="drug drug_general" data-topicid="9622" href="/d/drug information/9622.html" rel="external">methacholine</a> bronchoprovocation tests compared with 7 percent of those without esophagitis. Six months of acid suppression therapy (<a class="drug drug_general" data-topicid="9474" href="/d/drug information/9474.html" rel="external">pantoprazole</a> 40 mg daily) reduced positive methacholine test frequency to 13 percent of esophagitis patients showing that airway hyper-reactivity frequency can be reduced in non-asthmatics with esophagitis with GE reflux therapy [<a href="#rid35">35</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In 92 asthmatics, peripheral airway and total airway resistance were significantly higher in asthmatics with GE reflux symptoms than in asthmatics without GE reflux symptoms [<a href="#rid36">36</a>].</p><p></p><p class="headingAnchor" id="H6"><span class="h2">Microaspiration</span><span class="headingEndMark"> — </span>Microaspiration refers to the inhalation into the lungs of tiny amounts of refluxate from the stomach. This fluid can have a low pH from acidic gastric secretions or a weakly acidic or alkaline pH when the refluxate comes from achlorhydric conditions (eg, atrophic gastritis, use of acid suppressive medication) or from the small bowel.</p><p>Esophageal acid causes bronchoconstriction by a vagally mediated reflex. This response is further augmented if microaspiration is present (<a class="graphic graphic_figure graphicRef80770" href="/d/graphic/80770.html" rel="external">figure 2</a>). Much of the evidence supporting a role for microaspiration of acid in reflux-induced bronchoconstriction comes from animal studies that found an increase in airway resistance after inhalational or intratracheal exposure to acid [<a href="#rid37">37-39</a>].</p><p>There is conflicting evidence from human studies [<a href="#rid40">40</a>]. Among 78 patients with asthma, no correlation was found between bronchoalveolar lavage pepsin levels and asthma severity. Further, no association was noted between BAL pepsin and asthma control, lung function, BAL eosinophil or neutrophil counts, or <a class="drug drug_general" data-topicid="9180" href="/d/drug information/9180.html" rel="external">barium</a> swallow evidence of reflux [<a href="#rid40">40</a>]. In four patients with coexisting asthma and GE reflux, pH probes were placed into the trachea and esophagus [<a href="#rid41">41</a>]. Thirty-seven episodes of esophageal reflux lasting more than five minutes caused a mean decrease in PEF of 8 L/min. During five of these episodes, there was also a fall in tracheal pH, associated with a decrease in PEF of 84 L/min.</p><p>Gastric contents that are active in a nonacidic environment can also damage the upper airway epithelium. As an example, pepsin present in gastric juice, is active even in nonacidic pH and is endocytosed by epithelial cells in the upper airways, causing tissue damage [<a href="#rid42">42</a>]. A specific proteomic signature of GE reflux has been noted in induced sputum of patients with severe asthma (compared with less severe asthma and controls) suggesting the presence of a distinct airways phenotype [<a href="#rid43">43</a>]. This phenotype is characterized by elevated amounts of antimicrobial proteins and reduced amounts of proteins that are linked to epithelial integrity. Further evaluation noted three clusters of epithelial gene expression in patients with severe asthma and obesity, GE reflux and proton pump inhibitor treatment [<a href="#rid44">44</a>]. Further research is needed before changing current management strategies. </p><p class="headingAnchor" id="H11"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>Characteristics that may predict asthma improvement with GE reflux therapy include symptoms of regurgitation [<a href="#rid45">45</a>], nocturnal asthma symptoms [<a href="#rid8">8</a>], and concurrent symptoms of GE reflux and asthma [<a href="#rid8">8,9,46,47</a>]. As a result, patients with asthma should be questioned about esophageal and extraesophageal manifestations of GE reflux (<a class="graphic graphic_table graphicRef55234" href="/d/graphic/55234.html" rel="external">table 1</a>).</p><p>Careful questioning is needed since patients with asthma may not spontaneously identify their symptoms as being related to GERD [<a href="#rid46">46,48,49</a>]. Alternatively, some symptoms that are attributed to asthma may actually be due to GERD. For example, chest tightness may be misinterpreted as asthma, when it is actually due to GERD and cough may be caused by GERD in the absence of asthma.</p><p>Pertinent historical findings include:</p><p class="bulletIndent1"><span class="glyph">●</span>Asthma symptoms (cough, dyspnea, and/or wheezing) may be associated with a GE reflux episode, or the patient may use an inhaler while experiencing GE reflux symptoms [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Asthma symptoms are noticed after eating a high fat meal or foods that lower the lower esophageal sphincter (LES) pressure, such as chocolate, peppermint, caffeine, or alcohol [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The patient is taking asthma medication that may promote GE reflux by decreasing LES pressure (eg, <a class="drug drug_general" data-topicid="10281" href="/d/drug information/10281.html" rel="external">theophylline</a> and systemic or inhaled beta agonists) or possibly by increasing esophageal acid contact time (eg, oral <a class="drug drug_general" data-topicid="9809" href="/d/drug information/9809.html" rel="external">prednisone</a>) [<a href="#rid3">3,50,51</a>].</p><p></p><p class="headingAnchor" id="H2727024071"><span class="h1">DIAGNOSIS OF GERD IN PATIENTS WITH ASTHMA</span><span class="headingEndMark"> — </span>The diagnosis of GERD in patients with asthma is often a clinical diagnosis, based on the presence of classic symptoms of GE reflux (eg, heartburn and/or regurgitation). There is no esophageal or respiratory diagnostic test that identifies GE reflux treatment-responsive asthma. For patients with symptoms that are suspicious for GERD but atypical, the next step would be to refer to a gastroenterologist for clinical evaluation and further diagnostic workup [<a href="#rid52">52</a>]. (See  <a class="medical medical_review" href="/d/html/2265.html" rel="external">"Clinical manifestations and diagnosis of gastroesophageal reflux in adults", section on 'Diagnosis'</a>.)</p><p class="headingAnchor" id="H4242884467"><span class="h1">MANAGEMENT OF PATIENTS WITHOUT SYMPTOMS OF GERD</span><span class="headingEndMark"> — </span>Clinically silent GE reflux has been identified in 24 to 62 percent of patients with asthma and early studies suggested that treatment of GE reflux improved asthma control in patients with severe or difficult to control asthma [<a href="#rid46">46,53,54</a>]. However, three clinical trials demonstrated that treatment with proton pump inhibitors did not improve asthma outcomes in the absence of GE reflux symptoms [<a href="#rid8">8,9,55</a>]. Thus, empiric proton pump inhibitor therapy is not indicated in patients with asthma and no symptoms suggestive of GE reflux.</p><p>The clinical trials reported the following findings:</p><p class="bulletIndent1"><span class="glyph">●</span>In a study that randomly assigned 412 patients with poorly controlled asthma and minimal to no symptoms of reflux, no difference was found in the number of episodes of poor asthma control between the group taking <a class="drug drug_general" data-topicid="9104" href="/d/drug information/9104.html" rel="external">esomeprazole</a> 40 mg twice daily and that taking placebo for 24 weeks [<a href="#rid9">9</a>]. The outcomes were not affected by the presence or absence of GE reflux determined by pH probe monitoring.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the Study of Acid Reflux in Children With Asthma, 306 children with poorly controlled asthma, but without GE reflux symptoms, were randomly assigned to <a class="drug drug_general" data-topicid="9546" href="/d/drug information/9546.html" rel="external">lansoprazole</a> (15 mg/day if weighing less than 30 kg or 30 mg/day if weighing 30 kg or more) or placebo for 24 weeks [<a href="#rid55">55</a>]. No differences in the asthma control questionnaire (ACQ) scores or lung function were noted. Among 115 children with pH probe monitoring results, 49 (43 percent) had evidence of reflux; no difference in asthma outcomes was noted in this subgroup, although the number of patients was small.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a separate study, among 201 patients with moderate to severe asthma but no symptoms of reflux, no improvement was seen in peak expiratory flow rate measurements during 16 weeks of treatment with <a class="drug drug_general" data-topicid="9104" href="/d/drug information/9104.html" rel="external">esomeprazole</a> 40 mg twice daily compared with placebo [<a href="#rid8">8</a>].</p><p></p><p class="headingAnchor" id="H12"><span class="h1">EMPIRIC THERAPY IN PATIENTS WITH SYMPTOMATIC GERD</span></p><p class="headingAnchor" id="H2978171031"><span class="h2">Our approach</span><span class="headingEndMark"> — </span>For patients with moderate to severe asthma and symptoms of GE reflux, particularly those with regurgitation symptoms or nocturnal asthma, we suggest empiric therapy with a proton pump inhibitor (PPI) taken twice daily, 30 minutes before breakfast and dinner for two to three months. PPIs are preferred because they inhibit gastric acid secretion more effectively than H2 blockers [<a href="#rid56">56</a>]. Twice daily therapy is preferred because that was the regimen used in clinical trials, and once daily PPI therapy did not control esophageal acid exposure times in 27 percent of asthmatics with GE reflux [<a href="#rid45">45</a>]. (See  <a class="medical medical_review" href="/d/html/2258.html" rel="external">"Medical management of gastroesophageal reflux disease in adults"</a>.) </p><p>The Clinical Practice Updates Committee of the American Gastroenterological Association (AGA) recommends empiric therapy with aggressive acid suppression for six to eight weeks in patients with extraesophageal manifestations of GE reflux, including asthma [<a href="#rid52">52</a>]. </p><p>All patients should be instructed about lifestyle modifications for GE reflux. (See  <a class="medical medical_review" href="/d/html/2258.html" rel="external">"Medical management of gastroesophageal reflux disease in adults", section on 'Lifestyle and dietary modification'</a>.)</p><p class="headingAnchor" id="H3749823634"><span class="h3">Evidence that GERD treatment improves asthma</span><span class="headingEndMark"> — </span>A number of controlled and uncontrolled trials have found an association between GE reflux therapy and improved asthma symptoms among patients with symptomatic GERD. However, the impact of GE reflux therapy on objective outcome measures of asthma control has been variable [<a href="#rid8">8,45,46,53,57-68</a>].</p><p>For patients with both asthma and symptoms of GE reflux, the best evidence that PPI therapy improves some asthma outcomes derived from three large, randomized controlled trials that evaluated high-dose PPI therapy.</p><p class="bulletIndent1"><span class="glyph">●</span>One trial randomly assigned 207 patients with moderate to severe asthma plus reflux symptoms to receive <a class="drug drug_general" data-topicid="9546" href="/d/drug information/9546.html" rel="external">lansoprazole</a> (30 mg) or placebo twice daily for 24 weeks [<a href="#rid47">47</a>]. The primary outcome, asthma symptoms, and the secondary outcomes, peak expiratory flow (PEF) and forced expiratory volume in one second (FEV<sub>1</sub>), did not improve. However, lansoprazole therapy improved Asthma Quality of Life Questionnaire scores and decreased asthma exacerbations.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A randomized trial that compared <a class="drug drug_general" data-topicid="9104" href="/d/drug information/9104.html" rel="external">esomeprazole</a> 40 mg once or twice daily to placebo followed 961 patients with moderate to severe asthma and symptoms suggestive of GE reflux disease (GERD) for 26 weeks [<a href="#rid69">69</a>]. In the esomeprazole-treated patients, small, but significant improvements were noted in morning PEF rates, the Asthma Quality of Life Questionnaire total score, and the FEV<sub>1</sub>.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another trial randomly assigned 770 patients with persistent moderate to severe asthma who were being treated with asthma anti-inflammatory medication to receive <a class="drug drug_general" data-topicid="9104" href="/d/drug information/9104.html" rel="external">esomeprazole</a> (40 mg) or placebo twice daily for 16 weeks in addition to current asthma therapy [<a href="#rid8">8</a>]. Among patients with both nocturnal respiratory symptoms and GE reflux, esomeprazole improved PEF in the morning (8.7 L/min) and evening (10.2 L/min). No significant improvement in PEF was detected among patients without both GERD and nocturnal asthma symptoms.</p><p></p><p class="headingAnchor" id="H3327005023"><span class="h2">Improvement in asthma and GERD</span><span class="headingEndMark"> — </span>Asthma improvement during a three-month empiric trial of twice daily PPI therapy in combination with appropriate lifestyle modifications for GERD is considered diagnostic of GE reflux-triggered asthma. A successful trial may be defined as a 20 percent improvement in peak expiratory flow rates, an improvement in asthma symptoms, or a 20 percent decrease in oral glucocorticoid dose [<a href="#rid45">45</a>]. (See  <a class="medical medical_review" href="/d/html/2258.html" rel="external">"Medical management of gastroesophageal reflux disease in adults", section on 'Lifestyle and dietary modification'</a>.)</p><p>If the empiric trial is successful, we usually continue PPI therapy along with lifestyle modifications, although the PPI dose is often decreased to once daily. Twice daily therapy is resumed if the symptoms recur on the lower dose. Careful monitoring of asthma control should accompany decreases in the PPI dose or discontinuation. It is not known whether substituting an H2 blocker for the PPI will provide comparable control of GE reflux-triggered asthma.</p><p>GE reflux is a chronic remitting disorder, and most patients require protracted therapy. (See  <a class="medical medical_review" href="/d/html/2239.html" rel="external">"Approach to refractory gastroesophageal reflux disease in adults", section on 'Residual acid reflux'</a>.)</p><p class="headingAnchor" id="H3943319144"><span class="h2">Improvement in GERD not asthma</span><span class="headingEndMark"> — </span>If esophageal symptoms improve with therapy but symptoms and objective measures of asthma do not, it is possible that the patient has GE reflux, but it does not trigger asthma. In this situation, GE reflux would be managed according to usual guidelines. (See  <a class="medical medical_review" href="/d/html/2258.html" rel="external">"Medical management of gastroesophageal reflux disease in adults"</a>.)</p><p class="headingAnchor" id="H14"><span class="h2">Asthma refractory to initial GE reflux therapy</span><span class="headingEndMark"> — </span>If the empiric therapeutic trial is unsuccessful (ie, no significant improvement in asthma symptoms, peak expiratory flow rate, or systemic glucocorticoid requirement), either asthma is not triggered by GE reflux and GE reflux therapy can be discontinued, or GE reflux was not adequately controlled. To distinguish between these possibilities, esophageal testing can be performed. </p><p class="headingAnchor" id="H16"><span class="h3">Esophageal pH testing and combined esophageal impedance-pH testing</span><span class="headingEndMark"> — </span>We typically obtain esophageal pH testing in patients who have symptoms suggestive of GERD that are refractory to PPI therapy. When interpreting pH probe data, the percentage time with the intraesophageal pH below 4 is the most useful outcome measure in discriminating between physiologic and pathologic esophageal reflux. Esophageal pH testing is accepted as the standard to diagnose GE reflux with a sensitivity of 93 percent and specificity of 95 percent. Esophageal pH testing also allows correlation of asthma symptoms with esophageal acid events. Limitations of this testing include false negatives and inability to determine the degree to which GE reflux affects a patient's asthma over time [<a href="#rid6">6,70,71</a>]. (See  <a class="medical medical_review" href="/d/html/2265.html" rel="external">"Clinical manifestations and diagnosis of gastroesophageal reflux in adults", section on 'Ambulatory esophageal pH monitoring'</a>.)</p><p>Esophageal multichannel intraluminal impedance testing is helpful, when combined with pH probe testing, for detection of gastroesophageal reflux independent of pH (ie, both acid and non-acid reflux); however, this testing is not available at many centers. (See  <a class="medical medical_review" href="/d/html/2248.html" rel="external">"Esophageal multichannel intraluminal impedance testing"</a>.)</p><p>An AGA Clinical Practice Update advises that a lack of response to aggressive acid suppressive therapy combined with normal pH testing while <strong>off</strong> GE reflux therapy or impedance-pH testing while <strong>on</strong> GE reflux therapy significantly reduces the likelihood that GE reflux is a contributing etiology in asthma [<a href="#rid52">52</a>]. </p><p>The AGA guideline for esophageal pH recording, as well as other AGA guidelines, can be accessed through the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.gastrojournal.org%2Farticle%2FS0016-5085%2808%2901606-5%2Ffulltext&amp;token=F%2F33Yq3Lpx4WKgz%2BcwHiE9p1GE%2BqoK26USpkSQI8w7DE5baFcoIGz0ViLtOZsuVZAO7z5ujWAgVHOCca7UZ82TBLNngzdnvgSOl5ncIeeS4%3D&amp;TOPIC_ID=571" target="_blank">AGA web site</a>.</p><p class="headingAnchor" id="H17"><span class="h3">GI referral and endoscopy</span><span class="headingEndMark"> — </span>Referral to a gastroenterologist is indicated if GE reflux is not controlled on twice daily proton pump inhibitor therapy or if the patient has alarming symptoms (eg, dysphagia, odynophagia, acute involuntary weight loss, or anemia) [<a href="#rid72">72</a>].</p><p>As a general rule, upper endoscopy is not indicated for the routine evaluation of patients with asthma and typical symptoms suggestive of GE reflux in the absence of alarming (eg, dysphagia, odynophagia, acute involuntary weight loss, or anemia) or refractory symptoms [<a href="#rid72">72</a>]. GI referral is recommended if eosinophilic esophagitis is suspected. (See  <a class="medical medical_review" href="/d/html/2265.html" rel="external">"Clinical manifestations and diagnosis of gastroesophageal reflux in adults", section on 'Upper gastrointestinal endoscopy'</a>.) </p><p>The indications for upper endoscopy to evaluate for Barrett's esophagus in patients who require long-term proton pump inhibitor (PPI) therapy is discussed separately. (See  <a class="medical medical_review" href="/d/html/2269.html" rel="external">"Barrett's esophagus: Epidemiology, clinical manifestations, and diagnosis", section on 'Screening patients for Barrett's esophagus'</a>.)</p><p class="headingAnchor" id="H19"><span class="h3">GE reflux surgery</span><span class="headingEndMark"> — </span>Consensus has not been achieved on the role of surgery (eg, fundoplication) in patients with asthma-associated gastroesophageal (GE) reflux [<a href="#rid73">73</a>]. Surgical fundoplication for refractory GERD can be useful in selected patients; however, patients may still require medical therapy for GERD after fundoplication. (See  <a class="medical medical_review" href="/d/html/2278.html" rel="external">"Surgical treatment of gastroesophageal reflux in adults"</a>.) </p><p>The AGA clinical Practice Update on Extraesophageal GERD notes that a cautious approach should be taken before recommending fundoplication. Surgical fundoplication might be beneficial in patients with a known response of asthma symptoms to PPI therapy who are: (1) unwilling to take PPIs chronically and/or (2) have side effects with PPI therapy or (3) have continued troublesome regurgitation despite PPI therapy [<a href="#rid52">52</a>]. </p><p>Several studies suggest that surgical therapy is associated with improved asthma symptom control; however, there is little compelling evidence that fundoplication improves pulmonary function in patients with airway obstruction, particularly in patients without symptoms of GERD [<a href="#rid1">1,57,74,75</a>]. A systematic review of 24 studies (only two of which were controlled) estimated that antireflux surgery improved asthma symptoms by 79 percent, but had little effect on pulmonary function [<a href="#rid57">57</a>]. </p><p>In an uncontrolled study performed after the systematic review, 136 patients with severe, steroid-dependant asthma and active GE reflux still occurring by objective testing despite four to eight weeks of aggressive acid suppressive therapy underwent laparoscopic Nissen fundoplication with concomitant hiatal hernia repair (if present) [<a href="#rid76">76</a>]. After an average follow-up of 24 months, asthma and GE-reflux symptom scores were significantly reduced from pre-operative values. Participants with hiatal hernia (59 percent) had significantly better asthma outcomes (symptoms and asthma medication use) compared with those without hiatal hernia. Multicenter, randomized trials are needed before recommending fundoplication (with or without hiatal hernia repair) for steroid-dependant asthma with difficult to control GE reflux.</p><p class="headingAnchor" id="H1492755211"><span class="h3">Other tests</span><span class="headingEndMark"> — </span>Other diagnostic modalities, such as <a class="drug drug_general" data-topicid="9180" href="/d/drug information/9180.html" rel="external">barium</a> swallow, capsule endoscopy, <em>Helicobacter pylori</em> testing, technetium-99 sulfur colloid scintigraphic monitoring, salivary pepsin, esophageal mucosal impedance, and inspection of sputum for lipid-laden macrophages, are not recommended for evaluation of GERD in patients with asthma because of unacceptably low sensitivities and specificities [<a href="#rid20">20,52,77,78</a>]. (See  <a class="medical medical_review" href="/d/html/2265.html" rel="external">"Clinical manifestations and diagnosis of gastroesophageal reflux in adults"</a>.)</p><p class="headingAnchor" id="H20"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, “The Basics” and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on “patient info” and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/2011.html" rel="external">"Patient education: Gastroesophageal reflux disease in adults (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H21"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Gastroesophageal (GE) reflux is common among patients with asthma. Reciprocally, respiratory symptoms, including those associated with asthma, are increased among patients with GE reflux. Estimates of the prevalence of GE reflux among patients with asthma have varied from 30 to 90 percent. (See <a class="local">'Prevalence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Three potential mechanisms have been proposed whereby esophageal acid may produce bronchoconstriction and therefore exacerbate airflow obstruction in asthmatics: increased vagal tone, heightened bronchial reactivity, and microaspiration of gastric contents into the upper airway. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with asthma should be questioned about esophageal and extraesophageal manifestations of GE reflux (<a class="graphic graphic_table graphicRef55234" href="/d/graphic/55234.html" rel="external">table 1</a>). Pertinent historical findings include asthma symptoms during an episode of GE reflux, use of an inhaler while experiencing GE reflux symptoms, or asthma symptoms after eating certain foods (eg, high fat food, chocolate, peppermint, caffeine, alcohol). (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Characteristics that may predict asthma improvement with GE reflux therapy include symptoms of regurgitation and nocturnal asthma symptoms. (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with coexisting moderate to severe asthma and GE reflux symptoms, we suggest a trial of robust therapy for GE reflux (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>). Such therapy consists of a proton pump inhibitor (eg, <a class="drug drug_general" data-topicid="9718" href="/d/drug information/9718.html" rel="external">omeprazole</a>, <a class="drug drug_general" data-topicid="9104" href="/d/drug information/9104.html" rel="external">esomeprazole</a>, <a class="drug drug_general" data-topicid="9546" href="/d/drug information/9546.html" rel="external">lansoprazole</a>, <a class="drug drug_general" data-topicid="9519" href="/d/drug information/9519.html" rel="external">rabeprazole</a>, or <a class="drug drug_general" data-topicid="9474" href="/d/drug information/9474.html" rel="external">pantoprazole</a>) administered twice per day for two to three months (taken 30 minutes before breakfast and dinner) and lifestyle measures, such as weight loss for overweight individuals and elevation of the head of the bed for those with nocturnal symptoms. (See <a class="local">'Empiric therapy in patients with symptomatic GERD'</a> above and  <a class="medical medical_review" href="/d/html/2258.html" rel="external">"Medical management of gastroesophageal reflux disease in adults", section on 'Lifestyle and dietary modification'</a> and  <a class="medical medical_review" href="/d/html/2258.html" rel="external">"Medical management of gastroesophageal reflux disease in adults", section on 'Proton pump inhibitors'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chronic GE reflux therapy is included in ongoing treatment regimen, if the empiric therapeutic trial is successful. A successful trial is defined as a 20 percent improvement in peak expiratory flow rates, an improvement in asthma symptoms, or a 20 percent decrease in oral glucocorticoid dose. (See <a class="local">'Improvement in asthma and GERD'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Alternatively, if the empiric therapeutic trial is unsuccessful, either asthma is not triggered by GE reflux and GE reflux therapy can be discontinued, or GE reflux was not adequately controlled. A 24-hour esophageal pH test, or combined esophageal impedance and pH test, performed with the patient on antireflux therapy, can distinguish between these possibilities. (See <a class="local">'Asthma refractory to initial GE reflux therapy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Proton pump inhibitor therapy is not indicated for patients with asthma and no symptoms suggestive of GE reflux. (See <a class="local">'Management of patients without symptoms of GERD'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Referral to a gastroenterologist is prudent if GE reflux symptoms are not controlled on twice daily proton pump inhibitor therapy or if patients report alarming symptoms including dysphagia, odynophagia, hematemesis, melena, persistent vomiting (ie, 7 to 10 days), acute involuntary weight loss, or anemia. (See <a class="local">'GI referral and endoscopy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Consensus has not been achieved on the role of surgery in patients with asthma exacerbated by GE reflux; endoscopic therapies for GE reflux are considered experimental in this population. (See <a class="local">'GE reflux surgery'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Simpson WG. Gastroesophageal reflux disease and asthma. Diagnosis and management. Arch Intern Med 1995; 155:798.</a></li><li><a class="nounderline abstract_t">Chipps BE, Haselkorn T, Paknis B, et al. More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II. J Allergy Clin Immunol 2018; 141:1590.</a></li><li><a class="nounderline abstract_t">Naik RD, Vaezi MF. Extra-esophageal gastroesophageal reflux disease and asthma: understanding this interplay. Expert Rev Gastroenterol Hepatol 2015; 9:969.</a></li><li><a class="nounderline abstract_t">Paoletti G, Melone G, Ferri S, et al. Gastroesophageal reflux and asthma: when, how, and why. Curr Opin Allergy Clin Immunol 2021; 21:52.</a></li><li><a class="nounderline abstract_t">King-Biggs MB. Asthma. Ann Intern Med 2019; 171:ITC49.</a></li><li><a class="nounderline abstract_t">Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2013; 108:308.</a></li><li><a class="nounderline abstract_t">Nordenstedt H, Nilsson M, Johansson S, et al. The relation between gastroesophageal reflux and respiratory symptoms in a population-based study: the Nord-Trøndelag health survey. Chest 2006; 129:1051.</a></li><li><a class="nounderline abstract_t">Kiljander TO, Harding SM, Field SK, et al. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2006; 173:1091.</a></li><li><a class="nounderline abstract_t">American Lung Association Asthma Clinical Research Centers, Mastronarde JG, Anthonisen NR, et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 2009; 360:1487.</a></li><li><a class="nounderline abstract_t">Harding SM. Gastroesophageal reflux: a potential asthma trigger. Immunol Allergy Clin North Am 2005; 25:131.</a></li><li><a class="nounderline abstract_t">Kiljander TO, Laitinen JO. The prevalence of gastroesophageal reflux disease in adult asthmatics. Chest 2004; 126:1490.</a></li><li><a class="nounderline abstract_t">Sontag SJ, Schnell TG, Miller TQ, et al. Prevalence of oesophagitis in asthmatics. Gut 1992; 33:872.</a></li><li><a class="nounderline abstract_t">Sontag SJ, O'Connell S, Khandelwal S, et al. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 1990; 99:613.</a></li><li><a class="nounderline abstract_t">Field SK, Underwood M, Brant R, Cowie RL. Prevalence of gastroesophageal reflux symptoms in asthma. Chest 1996; 109:316.</a></li><li><a class="nounderline abstract_t">Campo S, Morini S, Re MA, et al. Esophageal dysmotility and gastroesophageal reflux in intrinsic asthma. Dig Dis Sci 1997; 42:1184.</a></li><li><a class="nounderline abstract_t">Vincent D, Cohen-Jonathan AM, Leport J, et al. Gastro-oesophageal reflux prevalence and relationship with bronchial reactivity in asthma. Eur Respir J 1997; 10:2255.</a></li><li><a class="nounderline abstract_t">Harding SM, Guzzo MR, Richter JE. 24-h esophageal pH testing in asthmatics: respiratory symptom correlation with esophageal acid events. Chest 1999; 115:654.</a></li><li><a class="nounderline abstract_t">Tan WC, Martin RJ, Pandey R, Ballard RD. Effects of spontaneous and simulated gastroesophageal reflux on sleeping asthmatics. Am Rev Respir Dis 1990; 141:1394.</a></li><li><a class="nounderline abstract_t">Harding SM. Nocturnal asthma: role of nocturnal gastroesophageal reflux. Chronobiol Int 1999; 16:641.</a></li><li><a class="nounderline abstract_t">Harding SM, Sontag SJ. Asthma and gastroesophageal reflux. Am J Gastroenterol 2000; 95:S23.</a></li><li><a class="nounderline abstract_t">Havemann BD, Henderson CA, El-Serag HB. The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut 2007; 56:1654.</a></li><li><a class="nounderline abstract_t">Cheung TK, Lam B, Lam KF, et al. Gastroesophageal reflux disease is associated with poor asthma control, quality of life, and psychological status in Chinese asthma patients. Chest 2009; 135:1181.</a></li><li><a class="nounderline abstract_t">DiMango E, Holbrook JT, Simpson E, et al. Effects of asymptomatic proximal and distal gastroesophageal reflux on asthma severity. Am J Respir Crit Care Med 2009; 180:809.</a></li><li><a class="nounderline abstract_t">Yildiz F, Mungan D, Gemicioglu B, et al. Asthma phenotypes in Turkey: a multicenter cross-sectional study in adult asthmatics; PHENOTURK study. Clin Respir J 2017; 11:210.</a></li><li><a class="nounderline abstract_t">Kannan JA, Bernstein DI, Bernstein CK, et al. Significant predictors of poor quality of life in older asthmatics. Ann Allergy Asthma Immunol 2015; 115:198.</a></li><li><a class="nounderline abstract_t">Blakey JD, Price DB, Pizzichini E, et al. Identifying Risk of Future Asthma Attacks Using UK Medical Record Data: A Respiratory Effectiveness Group Initiative. J Allergy Clin Immunol Pract 2017; 5:1015.</a></li><li><a class="nounderline abstract_t">Shimizu Y, Dobashi K, Zhao JJ, et al. Proton pump inhibitor improves breath marker in moderate asthma with gastroesophageal reflux disease. Respiration 2007; 74:558.</a></li><li><a class="nounderline abstract_t">Mansfield LE, Hameister HH, Spaulding HS, et al. The role of the vague nerve in airway narrowing caused by intraesophageal hydrochloric acid provocation and esophageal distention. Ann Allergy 1981; 47:431.</a></li><li><a class="nounderline abstract_t">Schan CA, Harding SM, Haile JM, et al. Gastroesophageal reflux-induced bronchoconstriction. An intraesophageal acid infusion study using state-of-the-art technology. Chest 1994; 106:731.</a></li><li><a class="nounderline abstract_t">Wright RA, Miller SA, Corsello BF. Acid-induced esophagobronchial-cardiac reflexes in humans. Gastroenterology 1990; 99:71.</a></li><li><a class="nounderline abstract_t">Herve P, Denjean A, Jian R, et al. Intraesophageal perfusion of acid increases the bronchomotor response to methacholine and to isocapnic hyperventilation in asthmatic subjects. Am Rev Respir Dis 1986; 134:986.</a></li><li><a class="nounderline abstract_t">Amarasiri DL, Pathmeswaran A, de Silva HJ, Ranasinha CD. Response of the airways and autonomic nervous system to acid perfusion of the esophagus in patients with asthma: a laboratory study. BMC Pulm Med 2013; 13:33.</a></li><li><a class="nounderline abstract_t">Field SK. A critical review of the studies of the effects of simulated or real gastroesophageal reflux on pulmonary function in asthmatic adults. Chest 1999; 115:848.</a></li><li><a class="nounderline abstract_t">Field SK, Evans JA, Price LM. The effects of acid perfusion of the esophagus on ventilation and respiratory sensation. Am J Respir Crit Care Med 1998; 157:1058.</a></li><li><a class="nounderline abstract_t">Karbasi A, Ardestani ME, Ghanei M, Harandi AA. The association between reflux esophagitis and airway hyper-reactivity in patients with gastro-esophageal reflux. J Res Med Sci 2013; 18:473.</a></li><li><a class="nounderline abstract_t">Sharifi A, Ansarin K. Effect of gastroesophageal reflux disease on disease severity and characteristics of lung functional changes in patients with asthma. J Cardiovasc Thorac Res 2014; 6:223.</a></li><li><a class="nounderline abstract_t">Ricciardolo FL, Rado V, Fabbri LM, et al. Bronchoconstriction induced by citric acid inhalation in guinea pigs: role of tachykinins, bradykinin, and nitric oxide. Am J Respir Crit Care Med 1999; 159:557.</a></li><li><a class="nounderline abstract_t">Tuchman DN, Boyle JT, Pack AI, et al. Comparison of airway responses following tracheal or esophageal acidification in the cat. Gastroenterology 1984; 87:872.</a></li><li><a class="nounderline abstract_t">Sant'Ambrogio FB, Sant'Ambrogio G, Chung K. Effects of HCl-pepsin laryngeal instillations on upper airway patency-maintaining mechanisms. J Appl Physiol (1985) 1998; 84:1299.</a></li><li><a class="nounderline abstract_t">Hunt EB, Ward C, Power S, et al. The Potential Role of Aspiration in the Asthmatic Airway. Chest 2017; 151:1272.</a></li><li><a class="nounderline abstract_t">Jack CI, Calverley PM, Donnelly RJ, et al. Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastro-oesophageal reflux. Thorax 1995; 50:201.</a></li><li><a class="nounderline abstract_t">Pearson JP, Parikh S, Orlando RC, et al. Review article: reflux and its consequences--the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21-23 April 2010. Aliment Pharmacol Ther 2011; 33 Suppl 1:1.</a></li><li><a class="nounderline abstract_t">Tariq K, Schofield JPR, Nicholas BL, et al. Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma. Respir Med 2019; 150:66.</a></li><li><a class="nounderline abstract_t">Perotin JM, Schofield JPR, Wilson SJ, et al. Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux. Eur Respir J 2019; 53.</a></li><li><a class="nounderline abstract_t">Harding SM, Richter JE, Guzzo MR, et al. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med 1996; 100:395.</a></li><li><a class="nounderline abstract_t">Irwin RS, Curley FJ, French CL. Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol. Chest 1993; 103:1662.</a></li><li><a class="nounderline abstract_t">Littner MR, Leung FW, Ballard ED 2nd, et al. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 2005; 128:1128.</a></li><li><a class="nounderline abstract_t">Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med 2000; 162:2341.</a></li><li><a class="nounderline abstract_t">Liou A, Grubb JR, Schechtman KB, Hamilos DL. Causative and contributive factors to asthma severity and patterns of medication use in patients seeking specialized asthma care. Chest 2003; 124:1781.</a></li><li><a class="nounderline abstract_t">Crowell MD, Zayat EN, Lacy BE, et al. The effects of an inhaled beta(2)-adrenergic agonist on lower esophageal function: a dose-response study. Chest 2001; 120:1184.</a></li><li><a class="nounderline abstract_t">Lazenby JP, Guzzo MR, Harding SM, et al. Oral corticosteroids increase esophageal acid contact times in patients with stable asthma. Chest 2002; 121:625.</a></li><li><a class="nounderline abstract_t">Vaezi MF, Katzka D, Zerbib F. Extraesophageal Symptoms and Diseases Attributed to GERD: Where is the Pendulum Swinging Now? Clin Gastroenterol Hepatol 2018; 16:1018.</a></li><li><a class="nounderline abstract_t">Kiljander TO, Salomaa ER, Hietanen EK, Terho EO. Gastroesophageal reflux in asthmatics: A double-blind, placebo-controlled crossover study with omeprazole. Chest 1999; 116:1257.</a></li><li><a class="nounderline abstract_t">Harding SM, Guzzo MR, Richter JE. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. Am J Respir Crit Care Med 2000; 162:34.</a></li><li><a class="nounderline abstract_t">Writing Committee for the American Lung Association Asthma Clinical Research Centers, Holbrook JT, Wise RA, et al. Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA 2012; 307:373.</a></li><li><a class="nounderline abstract_t">Maton PN. Omeprazole. N Engl J Med 1991; 324:965.</a></li><li><a class="nounderline abstract_t">Field SK, Gelfand GA, McFadden SD. The effects of antireflux surgery on asthmatics with gastroesophageal reflux. Chest 1999; 116:766.</a></li><li><a class="nounderline abstract_t">Kiljander TO. The role of proton pump inhibitors in the management of gastroesophageal reflux disease-related asthma and chronic cough. Am J Med 2003; 115 Suppl 3A:65S.</a></li><li><a class="nounderline abstract_t">Meier JH, McNally PR, Punja M, et al. Does omeprazole (Prilosec) improve respiratory function in asthmatics with gastroesophageal reflux? A double-blind, placebo-controlled crossover study. Dig Dis Sci 1994; 39:2127.</a></li><li><a class="nounderline abstract_t">Teichtahl H, Kronborg IJ, Yeomans ND, Robinson P. Adult asthma and gastro-oesophageal reflux: the effects of omeprazole therapy on asthma. Aust N Z J Med 1996; 26:671.</a></li><li><a class="nounderline abstract_t">Boeree MJ, Peters FT, Postma DS, Kleibeuker JH. No effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a)symptomatic gastro-oesophageal reflux. Eur Respir J 1998; 11:1070.</a></li><li><a class="nounderline abstract_t">Levin TR, Sperling RM, McQuaid KR. Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux. Am J Gastroenterol 1998; 93:1060.</a></li><li><a class="nounderline abstract_t">Larrain A, Carrasco E, Galleguillos F, et al. Medical and surgical treatment of nonallergic asthma associated with gastroesophageal reflux. Chest 1991; 99:1330.</a></li><li><a class="nounderline abstract_t">Field SK, Sutherland LR. Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux?: a critical review of the literature. Chest 1998; 114:275.</a></li><li><a class="nounderline abstract_t">So JB, Zeitels SM, Rattner DW. Outcomes of atypical symptoms attributed to gastroesophageal reflux treated by laparoscopic fundoplication. Surgery 1998; 124:28.</a></li><li><a class="nounderline abstract_t">Coughlan JL, Gibson PG, Henry RL. Medical treatment for reflux oesophagitis does not consistently improve asthma control: a systematic review. Thorax 2001; 56:198.</a></li><li><a class="nounderline abstract_t">Gibson PG, Henry RL, Coughlan JL. Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev 2003; :CD001496.</a></li><li><a class="nounderline abstract_t">Chan WW, Chiou E, Obstein KL, et al. The efficacy of proton pump inhibitors for the treatment of asthma in adults: a meta-analysis. Arch Intern Med 2011; 171:620.</a></li><li><a class="nounderline abstract_t">Kiljander TO, Junghard O, Beckman O, Lind T. Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med 2010; 181:1042.</a></li><li class="breakAll">American Gastroenterological Association. Gastroesophageal Reflux Disease (GERD). http://www.gastro.org/guidelines/2008/09/16/gastroesophageal-reflux-disease-gerd (Accessed on August 03, 2017).</li><li><a class="nounderline abstract_t">Hirano I, Richter JE, Practice Parameters Committee of the American College of Gastroenterology. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol 2007; 102:668.</a></li><li class="breakAll">Dyspepsia and GERD. Institute for Clinical Systems Improvement (ICSI). Bloomington, MN 2004 www.icsi.org (Accessed on May 07, 2006).</li><li><a class="nounderline abstract_t">Sidwa F, Moore AL, Alligood E, Fisichella PM. Surgical Treatment of Extraesophageal Manifestations of Gastroesophageal Reflux Disease. World J Surg 2017; 41:2566.</a></li><li><a class="nounderline abstract_t">Rakita S, Villadolid D, Thomas A, et al. Laparoscopic Nissen fundoplication offers high patient satisfaction with relief of extraesophageal symptoms of gastroesophageal reflux disease. Am Surg 2006; 72:207.</a></li><li><a class="nounderline abstract_t">Sontag SJ, O'Connell S, Khandelwal S, et al. Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies. Am J Gastroenterol 2003; 98:987.</a></li><li><a class="nounderline abstract_t">Li ZT, Ji F, Han XW, et al. Contribution of hiatal hernia to asthma in patients with gastroesophageal reflux disease. Clin Respir J 2018; 12:1858.</a></li><li><a class="nounderline abstract_t">Reibman J, Marmor M, Filner J, et al. Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS One 2008; 3:e4060.</a></li><li><a class="nounderline abstract_t">Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 2008; 198:553.</a></li></ol></div><div id="topicVersionRevision">Topic 571 Version 30.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7717787" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Gastroesophageal reflux disease and asthma. Diagnosis and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28797732" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26067887" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Extra-esophageal gastroesophageal reflux disease and asthma: understanding this interplay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33369569" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Gastroesophageal reflux and asthma: when, how, and why.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31569251" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23419381" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Guidelines for the diagnosis and management of gastroesophageal reflux disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16608957" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The relation between gastroesophageal reflux and respiratory symptoms in a population-based study: the Nord-Trøndelag health survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16357331" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19357404" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Efficacy of esomeprazole for treatment of poorly controlled asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15579368" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Gastroesophageal reflux: a potential asthma trigger.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15539717" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The prevalence of gastroesophageal reflux disease in adult asthmatics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1644324" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Prevalence of oesophagitis in asthmatics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2379769" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8620699" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Prevalence of gastroesophageal reflux symptoms in asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9201082" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Esophageal dysmotility and gastroesophageal reflux in intrinsic asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9387949" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Gastro-oesophageal reflux prevalence and relationship with bronchial reactivity in asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10084471" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : 24-h esophageal pH testing in asthmatics: respiratory symptom correlation with esophageal acid events.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2350084" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Effects of spontaneous and simulated gastroesophageal reflux on sleeping asthmatics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10513887" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Nocturnal asthma: role of nocturnal gastroesophageal reflux.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10950102" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Asthma and gastroesophageal reflux.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17682001" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The association between gastro-oesophageal reflux disease and asthma: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19118263" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Gastroesophageal reflux disease is associated with poor asthma control, quality of life, and psychological status in Chinese asthma patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19661245" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Effects of asymptomatic proximal and distal gastroesophageal reflux on asthma severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26073091" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Asthma phenotypes in Turkey: a multicenter cross-sectional study in adult asthmatics; PHENOTURK study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26208758" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Significant predictors of poor quality of life in older asthmatics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28017629" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Identifying Risk of Future Asthma Attacks Using UK Medical Record Data: A Respiratory Effectiveness Group Initiative.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17389779" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Proton pump inhibitor improves breath marker in moderate asthma with gastroesophageal reflux disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7325414" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The role of the vague nerve in airway narrowing caused by intraesophageal hydrochloric acid provocation and esophageal distention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8082350" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Gastroesophageal reflux-induced bronchoconstriction. An intraesophageal acid infusion study using state-of-the-art technology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2344943" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Acid-induced esophagobronchial-cardiac reflexes in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3096180" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Intraesophageal perfusion of acid increases the bronchomotor response to methacholine and to isocapnic hyperventilation in asthmatic subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23724936" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Response of the airways and autonomic nervous system to acid perfusion of the esophagus in patients with asthma: a laboratory study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10084501" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : A critical review of the studies of the effects of simulated or real gastroesophageal reflux on pulmonary function in asthmatic adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9563719" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The effects of acid perfusion of the esophagus on ventilation and respiratory sensation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24250694" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The association between reflux esophagitis and airway hyper-reactivity in patients with gastro-esophageal reflux.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25610553" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Effect of gastroesophageal reflux disease on disease severity and characteristics of lung functional changes in patients with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9927373" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Bronchoconstriction induced by citric acid inhalation in guinea pigs: role of tachykinins, bradykinin, and nitric oxide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6468875" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Comparison of airway responses following tracheal or esophageal acidification in the cat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9516196" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Effects of HCl-pepsin laryngeal instillations on upper airway patency-maintaining mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28300572" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The Potential Role of Aspiration in the Asthmatic Airway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7701464" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastro-oesophageal reflux.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21366630" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Review article: reflux and its consequences--the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21-23 April 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30961953" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31023846" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8610725" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8404082" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16162697" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11112161" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14605049" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Causative and contributive factors to asthma severity and patterns of medication use in patients seeking specialized asthma care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11591558" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The effects of an inhaled beta(2)-adrenergic agonist on lower esophageal function: a dose-response study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11834680" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Oral corticosteroids increase esophageal acid contact times in patients with stable asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29427733" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Extraesophageal Symptoms and Diseases Attributed to GERD: Where is the Pendulum Swinging Now?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10559084" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Gastroesophageal reflux in asthmatics: A double-blind, placebo-controlled crossover study with omeprazole.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10903216" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22274684" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2002819" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Omeprazole.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10492285" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : The effects of antireflux surgery on asthmatics with gastroesophageal reflux.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12928078" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : The role of proton pump inhibitors in the management of gastroesophageal reflux disease-related asthma and chronic cough.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7924731" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Does omeprazole (Prilosec) improve respiratory function in asthmatics with gastroesophageal reflux? A double-blind, placebo-controlled crossover study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8958363" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Adult asthma and gastro-oesophageal reflux: the effects of omeprazole therapy on asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9648957" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : No effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a)symptomatic gastro-oesophageal reflux.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9672330" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2036812" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Medical and surgical treatment of nonallergic asthma associated with gastroesophageal reflux.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9674479" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux?: a critical review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9663248" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Outcomes of atypical symptoms attributed to gastroesophageal reflux treated by laparoscopic fundoplication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11182012" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Medical treatment for reflux oesophagitis does not consistently improve asthma control: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12804410" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Gastro-oesophageal reflux treatment for asthma in adults and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21482834" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : The efficacy of proton pump inhibitors for the treatment of asthma in adults: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20110554" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20110554" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17335450" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : ACG practice guidelines: esophageal reflux testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17335450" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : ACG practice guidelines: esophageal reflux testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28508234" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Surgical Treatment of Extraesophageal Manifestations of Gastroesophageal Reflux Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16553119" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Laparoscopic Nissen fundoplication offers high patient satisfaction with relief of extraesophageal symptoms of gastroesophageal reflux disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12809818" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29193785" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Contribution of hiatal hernia to asthma in patients with gastroesophageal reflux disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19112508" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Asthma is inversely associated with Helicobacter pylori status in an urban population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18598192" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Helicobacter pylori colonization is inversely associated with childhood asthma.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
